Log In Get Started
Press Releases April 30, 2026 11:23 AM

Voting Rights and Capital

Shell plc reports updated total voting rights and share capital figures as of April 30, 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
SHEL

Shell plc announced that as of April 30, 2026, its capital consists of 5,607,066,071 ordinary shares with no shares held in treasury. This update serves as a reference figure for shareholders to assess voting rights and disclosure requirements under the FCA's Transparency Rules. The figure includes shares involved in the ongoing share buy-back program but not yet cancelled.

Voting Rights and Capital
SHEL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Shell plc's total issued ordinary shares amount to 5,607,066,071 as of April 30, 2026.
  • No shares are held in treasury by Shell plc at this time.
  • The figure includes shares purchased via the share buy-back program but not yet cancelled, important for shareholder notifications under FCA rules.

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules, we hereby notify the market of the following:

Shell plc's capital as at April 30, 2026, consists of 5,607,066,071 ordinary shares of €0.07 each. Shell plc holds no shares in Treasury.

The figure, 5,607,066,071, may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Shell plc under the FCA's Disclosure Guidance and Transparency Rules.

Note: This announcement is made pursuant to Disclosure Guidance and Transparency Rule 5.6.1 and as such, the above figure includes shares purchased by Shell plc as part of its share buy-back programme but not yet cancelled.

Enquiries


Shell Media Relations
International +44 (0)207 934 5550; U.S. and Canada: Contact form


Risks

  • The share buy-back program shares are accounted for in total voting rights but remain subject to cancellation, causing possible future adjustments in shares outstanding.
  • Regulatory compliance requires precise disclosure of shareholdings, so any changes in the share structure could impact shareholder notifications and market perception.
  • Market fluctuations or unforeseen corporate actions could affect the share capital and voting rights beyond the reported figure.

More from Press Releases

Grace Therapeutics Announces $10 Million Private Placement Aug 4, 2026 Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering Aug 4, 2026 Rocket Lab Awarded $397 Million Contract to Build and Launch Flatellites for U.S. Space Force’s Space-Based Airborne Moving Target Indicator Program Aug 4, 2026 McEwen Q2 2026 Results Conference Call Aug 4, 2026 Sunrun Prices $267 Million Securitization of Residential Solar and Storage Assets Aug 4, 2026